Migraine market to reach $16.4 billion in 7MM by 2033, forecasts GlobalData
CGRP antagonists drive growth, but access and reimbursement barriers remain challenges
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
migraine
Akums launches Lasmiditan Tablet for migraine management
The medication is formulated to interrupt pain signals to the brain and address nerve inflammation contributing to migraine…
ZIM Labs gets marketing authorisation for Rizatriptan orally dissolving film in Portugal
Rizatriptan is widely used for relief from Migraine attacks
Ajanta Pharma receives US FDA approval for migraine drug
Zolmitriptan tablets are part of an 'ever-growing portfolio' that the company has developed for the US market Ajanta Pharma has…
Jubilant Life Sciences gets US FDA nod
The drug is indicated for the acute treatment of migraine in adults and paediatric patients Jubilant Life Sciences has received…
New blood biomarker for migraine identified
Women with migraine had an average of 5.6 headache days per month Researchers have identified a potential new marker found in the…
Novartis in global partnership with Amgen
To develop and commercialise pioneering neuroscience treatments Novartis has entered into a global collaboration with Amgen to…